chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Oropharyngeal pain, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: Narrative: COVID infection following COVID vaccine series 03/17, Pfizer, dose #1 04/07, Pfizer, dose #2 12/27 COVID swab, result: detected 12/30 COVID swab, result: detected 1/3 COVID swab, result: detected 12/27 pt cc: rhinorrhea, sore throat exposure: unknown
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Myalgia Narrative:  reports soreness in 1 arm (ipsalataral side from vaccine) for 2 mo after #2 dose. Vaccine administered in r deltoid #1 and #2 . She reports this today 1/24/22. This had occurred for a few months after #2 dose of moderna, and she states she has no pain in either arm at present. She states she has h/o superficial thromvophelvitis in 1 ue year ago. Is followed by her pcp.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: covid vaccine breakthrouh
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Acute myocardial infarction, COVID-19, Chest discomfort, Chest pain, Dyspnoea
Clinical narrative: Patient presented with a chief complaint of chest discomfort, shortness of. breath.  The patient was diagnosed with COVID-19 infection 2 days prior to admission.  She presented as her chest pain/heaviness got worse with radiation to her left arm with which she was admitted as she was found to have elevated troponin. Cardiology was consulted.    COVID-19 infection:  Patient is not hypoxic.  Given comorbidities she was evaluated for monoclonal antibody and that was administered February 2, 2022 after discussion with the patient and she was monitored overnight and she did not have any adverse.   Elevated troponin/non ST-elevation myocardial infarction/type 2 MI:  Cardiology has evaluated.  She had a transthoracic echocardiogram that did not show any wall motion abnormalities.  Cardiology has cleared her for discharge
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, SARS-CoV-2 test positive, Troponin increased
Clinical narrative: Patient presented with a chief complaint of chest discomfort, shortness of. breath.  The patient was diagnosed with COVID-19 infection 2 days prior to admission.  She presented as her chest pain/heaviness got worse with radiation to her left arm with which she was admitted as she was found to have elevated troponin. Cardiology was consulted.    COVID-19 infection:  Patient is not hypoxic.  Given comorbidities she was evaluated for monoclonal antibody and that was administered February 2, 2022 after discussion with the patient and she was monitored overnight and she did not have any adverse.   Elevated troponin/non ST-elevation myocardial infarction/type 2 MI:  Cardiology has evaluated.  She had a transthoracic echocardiogram that did not show any wall motion abnormalities.  Cardiology has cleared her for discharge
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Anticoagulant therapy, Blood potassium abnormal, COVID-19, Chest X-ray abnormal, Chest pain
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dialysis, Diarrhoea, Drug screen, Dyspnoea
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram normal, Ejection fraction normal, Fatigue, Haemoptysis, Hypervolaemia
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Influenza A virus test negative, Influenza B virus test, Lung infiltration, Malaise
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation decreased, Painful respiration, Pleuritic pain, Positive airway pressure therapy, Procalcitonin increased
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary congestion, Respiratory syncytial virus test negative, SARS-CoV-2 test positive, Tachypnoea, Troponin increased
Clinical narrative: Pt presented to the ED on 1/23 with CC of chest pain.    Per pt CP began on wed during dialysis.  She states pain was associated with dyspnea.  No radiation of pan.  Denied any palpitations or lightheadedness.  Worsening of CP with coughing or breathing.  She reported one episode of hemoptysis.  Also reported diarrhea with 2-3 loose stools per day for the past 3 days.  Also reported fatigue.  Denied any F/C.  Admits to cocaine and marijuana and tobacco use.  She did not feel well so missed dialysis on Friday.     In ED pt with VS of temperature 98.9°, heart rate 85, respiration rate 18, blood pressure 110/67, and sats of 74% on room air.   Influenza a and B negative, RSV negative, COVID-19 PCR positive.  Urine drug screen pending collection.  Chest x-ray with cardiomegaly and central vascular congestion/fluid overload.  Mild basilar airspace disease right greater than left with possible small right pleural effusion.  She has a patchy perihilar and lower lobe infiltrates in the right middle lobe changes may be related to COVID 19.     Pt was given vitamin-C, Decadron, aspirin, remdesivir, Neurontin, Norco, and started on heparin drip.  Cardiology and nephrology were consulted.  Pt was admitted for further workup.  Cardiology started pt on heparin gtt for 24 hours and transitioned to subQ heparin.  Echo was done and LVEF of 60%.  They felt chest pain due to COVID 19 and cough.     Nephrology ran two dialysis sessions subsequent days to help with fluid overload.  Her oral intake improved.  Her breathing improved.  Pt was started on IV abx for possible superimposed bacterial infection given elevated procalcitonin.    Pt was weaned off oxygen.  Home oxygen eval done and not needing oxygen.  Pt eager to go home.  Will d/c on remaining course of abx and 5 days of prednisone.  Pt will need close follow up with PCP.   She was discharged home with covid kit and told to monitor her oxygen levels if dropping < 90% she needs to come back to ED. Pt came back to the ED on 2/8/22.   She presented with symptoms of shortness of breath, patient was saturating 84% on room air.  Patient also missed her dialysis yesterday.  In ER patient was tachypneic, hypoxic, patient was placed on BiPAP. Patient received emergent dialysis, with which her symptoms improved, potassium normalized.  Patient received dialysis consecutively for 3 days.  Patient complaining of pleuritic chest pain, troponin was elevated, trended flat trend, no concerns of acute coronary syndrome.  Her oxygenation improved, patient is back to 2 L of oxygen, patient was discharged on home oxygen post covid infection which she should be continuing at home.
Age: 1.83
Sex: F
Vaccine: HEP
Symptoms: No adverse event, Product administered to patient of inappropriate age, Product lot number issue
Clinical narrative: It was written and checked that a Hep A Vaccine was administered but the lot number documented indicates it was a Hep B vaccine. There we no s/s that indicated any adverse reaction.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Aortic aneurysm, Dyspnoea, Hypoxia, Lung infiltration, Wheezing
Clinical narrative: CLINICAL IMPRESSION 1. Hypoxia  2. Wheezing  3. Pulmonary infiltrate  4. Shortness of breath  5. Thoracic aortic aneurysm without rupture
Age: 8.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient given a Pfizer vaccine indicated for 12 and older. Patient is 8 years old.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Eye movement disorder, Hyperhidrosis, Hypotonia, Syncope, Unresponsive to stimuli
Clinical narrative: A COUPLE MINUTES AFTER ADMINISTERING VACCINE, PATIENT WAS SITTING IN PHARMACY WAITING AREA FOR THE REQUIRED 15 MINUTE PERIOD. CUSTOMER ALERTED ME THAT HE WAS SLUMPED OVER. WENT OUT AND SAW PATIENT SLUMPED OVER WITH EYES CLOSED. PATIENT UNRESPONSIVE TO TOUCH AND SOUND. HE HAD A PULSE AND COULD VISIBLY SEE STOMACH MOVING SO HE WAS BREATHING. PATIENT SWEATING PROFUSELY AND FAINTED A COUPLE TIMES- EYES WERE ROLLING AROUND IN HEAD. CALLED 911 AND LAID PATIENT ON BACK ON THE FLOOR- STAYED WITH PATIENT UNTIL EMTS ARRIVED. GOT PATIENT A SODA TO DRINK BEFORE LEAVING. PATIENT DID STATE HE ONLY HAD A GRANOLA BAR BEFORE COMING FOR VACCINE AND IS NOT GOOD WITH SHOTS
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Atelectasis, Blood creatinine increased, Blood lactate dehydrogenase increased, Blood lactic acid
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood urea normal, C-reactive protein increased, COVID-19, Cardiac monitoring, Chest X-ray abnormal
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Electrocardiogram QT interval, Full blood count normal, Hyperglycaemia
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Hypertension, Hypoxia, Influenza virus test negative, Lactic acidosis, Metabolic function test
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test abnormal, Nausea, Pneumonia, Pneumonia bacterial, Procalcitonin
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, QRS axis, QRS axis abnormal, Respiratory syncytial virus test negative, SARS-CoV-2 test positive
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Serum ferritin normal, Sputum discoloured, Tachycardia, Troponin normal
Clinical narrative: Pt presented to the ED due to cough and shortness of breath.  Patient explains that she started developing a cough productive of yellow sputum 2 days ago, with gradually worsening shortness of breath, prompting her to come to the ED today for further evaluation.  She also complains of associated nausea, but denies any episode of vomiting.  Patient reports that she tried using her breathing treatments at home with no improvement of her symptoms.  She denies any fever, chest pain, diarrhea, or changes in bowel or bladder habits. Upon ambulating the patient in the room, she became hypoxic at 88% on room air. She did arrive tachycardic at 123 bpm and slightly hypertensive at 143/66. The patient was placed on a cardiac monitor, continuous pulse oximetry, and 2 L supplemental oxygen via nasal cannula with oxygen saturations noted at 95%. Multiple labs and a chest x-ray were ordered for further evaluation of her symptoms.   An EKG was obtained and showed normal sinus rhythm with a ventricular rate of 90, left axis deviation, normal intervals, peer 172, QRS 76, QTC 533, with no acute ischemic changes.   The chest x-ray was reviewed by the ED physician and read by the radiologist showing mild left midlung atelectasis or pneumonia.   COVID-19 is positive. Lactic acid is elevated at 2.7. Procalcitonin is elevated at 2.41. LD is elevated at 297. CRP is elevated at 4.76. Ferritin is normal at 80.5. CMP shows an elevated creatinine at 1.7, increased from baseline of 0.6, with a normal BUN of 14, and hyperglycemia at 212. CBC is essentially normal. Troponin is negative. RSV is negative. Influenza panel is negative.   An IV was established and she was given a 1 L NS bolus for hydration and lactic acidosis. She was also given 1 g Rocephin IVPB and 100 mg Doxycycline IV for bacterial pneumonia given her elevated procalcitonin.   Patient was admitted  for COVID-19, acute kidney injury, pneumonia, and lactic acidosis.  Patient left hospital against medical advice.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Hypoaesthesia
Clinical narrative: Portions of the left side of my face became numb and while some of the numbness faded, there is still less sensation in parts of my face and still feels a bit numb
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ascites, Asthenia, Blood phosphorus, COVID-19, Chest X-ray normal
Clinical narrative: 60yo F w/ hx breast cancer in remission, cirrhosis due to alcohol reportedly sober since 1/2022, and inflammatory arthritis on plaquenil admitted with FTT- decreased PO intake she said was due to having so much phlegm swallowed that it made her nauseated. Phlegm improved, still didn't eat. Resultant marked electrolyte abnormalities on admission with weakness. Also feeling "jittery". Exam pale w/ soft abdomen. Ascites fluid not consistent w/ dialysis and CXR clear, but markedly elevated procalcitonin is concerning. Therefore will continue rocephin and add doxy for now in case occult pneumonia vs SBP and await cultures/follow clinically. Check u/s + AFP to make sure no HCC causing FTT. Also w/ hx of esophageal rings s/p dilations, could consult GI for consideration for endoscopic dilation as she has noted more difficulty swallowing recently.      Other consideration is something like depression/anxiety causing the FTT. Says she is taking her medications, but hasn't been making in person appointments recently. Was assaulted by a neighbor in her apartment in early March per therapy notes so I think this is probably contributing to her current presentation. Also I am not certain she is maintaining her sobriety- but I think she probably is mostly telling the truth- would expect her phos to be lower and her lfts to be up more if she had started drinking regularly again. Consider psych consult for further med recs- she has prolonged qtc which limits ssri- not sure her SNRI is helping much.  Tested positive for COVID upon admission (3/22/22).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Dialysis, Dysphagia, Electrocardiogram QT prolonged, Electrolyte imbalance, Failure to thrive
Clinical narrative: 60yo F w/ hx breast cancer in remission, cirrhosis due to alcohol reportedly sober since 1/2022, and inflammatory arthritis on plaquenil admitted with FTT- decreased PO intake she said was due to having so much phlegm swallowed that it made her nauseated. Phlegm improved, still didn't eat. Resultant marked electrolyte abnormalities on admission with weakness. Also feeling "jittery". Exam pale w/ soft abdomen. Ascites fluid not consistent w/ dialysis and CXR clear, but markedly elevated procalcitonin is concerning. Therefore will continue rocephin and add doxy for now in case occult pneumonia vs SBP and await cultures/follow clinically. Check u/s + AFP to make sure no HCC causing FTT. Also w/ hx of esophageal rings s/p dilations, could consult GI for consideration for endoscopic dilation as she has noted more difficulty swallowing recently.      Other consideration is something like depression/anxiety causing the FTT. Says she is taking her medications, but hasn't been making in person appointments recently. Was assaulted by a neighbor in her apartment in early March per therapy notes so I think this is probably contributing to her current presentation. Also I am not certain she is maintaining her sobriety- but I think she probably is mostly telling the truth- would expect her phos to be lower and her lfts to be up more if she had started drinking regularly again. Consider psych consult for further med recs- she has prolonged qtc which limits ssri- not sure her SNRI is helping much.  Tested positive for COVID upon admission (3/22/22).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling jittery, Hypophagia, Liver function test, Nausea, Pallor
Clinical narrative: 60yo F w/ hx breast cancer in remission, cirrhosis due to alcohol reportedly sober since 1/2022, and inflammatory arthritis on plaquenil admitted with FTT- decreased PO intake she said was due to having so much phlegm swallowed that it made her nauseated. Phlegm improved, still didn't eat. Resultant marked electrolyte abnormalities on admission with weakness. Also feeling "jittery". Exam pale w/ soft abdomen. Ascites fluid not consistent w/ dialysis and CXR clear, but markedly elevated procalcitonin is concerning. Therefore will continue rocephin and add doxy for now in case occult pneumonia vs SBP and await cultures/follow clinically. Check u/s + AFP to make sure no HCC causing FTT. Also w/ hx of esophageal rings s/p dilations, could consult GI for consideration for endoscopic dilation as she has noted more difficulty swallowing recently.      Other consideration is something like depression/anxiety causing the FTT. Says she is taking her medications, but hasn't been making in person appointments recently. Was assaulted by a neighbor in her apartment in early March per therapy notes so I think this is probably contributing to her current presentation. Also I am not certain she is maintaining her sobriety- but I think she probably is mostly telling the truth- would expect her phos to be lower and her lfts to be up more if she had started drinking regularly again. Consider psych consult for further med recs- she has prolonged qtc which limits ssri- not sure her SNRI is helping much.  Tested positive for COVID upon admission (3/22/22).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Peritoneal fluid analysis abnormal, Procalcitonin increased, Productive cough, SARS-CoV-2 test positive, Ultrasound abdomen
Clinical narrative: 60yo F w/ hx breast cancer in remission, cirrhosis due to alcohol reportedly sober since 1/2022, and inflammatory arthritis on plaquenil admitted with FTT- decreased PO intake she said was due to having so much phlegm swallowed that it made her nauseated. Phlegm improved, still didn't eat. Resultant marked electrolyte abnormalities on admission with weakness. Also feeling "jittery". Exam pale w/ soft abdomen. Ascites fluid not consistent w/ dialysis and CXR clear, but markedly elevated procalcitonin is concerning. Therefore will continue rocephin and add doxy for now in case occult pneumonia vs SBP and await cultures/follow clinically. Check u/s + AFP to make sure no HCC causing FTT. Also w/ hx of esophageal rings s/p dilations, could consult GI for consideration for endoscopic dilation as she has noted more difficulty swallowing recently.      Other consideration is something like depression/anxiety causing the FTT. Says she is taking her medications, but hasn't been making in person appointments recently. Was assaulted by a neighbor in her apartment in early March per therapy notes so I think this is probably contributing to her current presentation. Also I am not certain she is maintaining her sobriety- but I think she probably is mostly telling the truth- would expect her phos to be lower and her lfts to be up more if she had started drinking regularly again. Consider psych consult for further med recs- she has prolonged qtc which limits ssri- not sure her SNRI is helping much.  Tested positive for COVID upon admission (3/22/22).
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Victim of crime
Clinical narrative: 60yo F w/ hx breast cancer in remission, cirrhosis due to alcohol reportedly sober since 1/2022, and inflammatory arthritis on plaquenil admitted with FTT- decreased PO intake she said was due to having so much phlegm swallowed that it made her nauseated. Phlegm improved, still didn't eat. Resultant marked electrolyte abnormalities on admission with weakness. Also feeling "jittery". Exam pale w/ soft abdomen. Ascites fluid not consistent w/ dialysis and CXR clear, but markedly elevated procalcitonin is concerning. Therefore will continue rocephin and add doxy for now in case occult pneumonia vs SBP and await cultures/follow clinically. Check u/s + AFP to make sure no HCC causing FTT. Also w/ hx of esophageal rings s/p dilations, could consult GI for consideration for endoscopic dilation as she has noted more difficulty swallowing recently.      Other consideration is something like depression/anxiety causing the FTT. Says she is taking her medications, but hasn't been making in person appointments recently. Was assaulted by a neighbor in her apartment in early March per therapy notes so I think this is probably contributing to her current presentation. Also I am not certain she is maintaining her sobriety- but I think she probably is mostly telling the truth- would expect her phos to be lower and her lfts to be up more if she had started drinking regularly again. Consider psych consult for further med recs- she has prolonged qtc which limits ssri- not sure her SNRI is helping much.  Tested positive for COVID upon admission (3/22/22).
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Arrhythmia, Dyspnoea, Heart rate increased, Hypertension, Myoclonus
Clinical narrative: myoclonic convulsions, high heart rate, high blood pressure, arrhythmia,  dyspnea, vertigo, trembling, lots of panic attacks and stress crisis and intense itching
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Panic attack, Pruritus, Stress, Tremor, Vertigo
Clinical narrative: myoclonic convulsions, high heart rate, high blood pressure, arrhythmia,  dyspnea, vertigo, trembling, lots of panic attacks and stress crisis and intense itching
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Anxiety, Asthenia, Balance disorder, Dizziness, Encephalitis
Clinical narrative: This was my second vaccine and my second adverse reaction.  An attack of vertigo came on suddenly, and I managed to get to a chair where I sat for over an hour not moving.  When my husband and son came home, they helped me walk to a couch and I was very weak and dizzy for the rest of the day. It took me a few days to feel back to normal.  I started taking physical therapy sessions a few weeks later which helped me become stronger and able to balance better, but did not eliminate the chronic dizziness.  In September, I had another severe attack of vertigo and was transported to the hospital.  I came home that night.  Dizziness continued and anxiety increased.  Another attack occurred on Thanksgiving which was the most severe.  I was very weak for several days.  In January I was diagnosed with PPPD andprescribed Venlafaxine for anxiety and dizziness.  The doctor said it would help alleviate the inflammation in the brain.  It has helped with the anxiety and dizziness, but I still experience the dizziness at times.  I have made progress, but am not cured.
Age: 75.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Gait disturbance, Persistent postural-perceptual dizziness, Vertigo
Clinical narrative: This was my second vaccine and my second adverse reaction.  An attack of vertigo came on suddenly, and I managed to get to a chair where I sat for over an hour not moving.  When my husband and son came home, they helped me walk to a couch and I was very weak and dizzy for the rest of the day. It took me a few days to feel back to normal.  I started taking physical therapy sessions a few weeks later which helped me become stronger and able to balance better, but did not eliminate the chronic dizziness.  In September, I had another severe attack of vertigo and was transported to the hospital.  I came home that night.  Dizziness continued and anxiety increased.  Another attack occurred on Thanksgiving which was the most severe.  I was very weak for several days.  In January I was diagnosed with PPPD andprescribed Venlafaxine for anxiety and dizziness.  The doctor said it would help alleviate the inflammation in the brain.  It has helped with the anxiety and dizziness, but I still experience the dizziness at times.  I have made progress, but am not cured.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Patient died the following day
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Lip swelling, Skin abrasion, Vaccination site swelling
Clinical narrative: She received RZV/ Shingrix #1 on 3/21/22 at clinic. Then she received #2 apparently on 3/26/22. Then she developed swelling 3x5 inches on the left upper arm just below the vaccine site. She also developed swollen lips and small painful excoriations on the lips. These symptoms have been roughly unchanged the past 1-2 days. She is currently afebrile, HR 105. She has no issues breathing. She is distressed by the symptoms and wonders if they are due to the RZV. She is able to eat and drink. She says she cannot blow the crossing guard whistle right now. Presumably her lip swelling and arm swelling are due to the RZV but I don't think she has angioedema.